Lynn Tyler of the Indianapolis office authored an article to the American Intellectual Property Association (AIPLA) Biotechnology Committee's monthly e-newsletter, the Biotech Buzz entitled, "FDA Approves First Biosimilar to a Monoclonal Antibody; Related Litigation is Progressing but Remains Pending."
Newsletters
Biotech Buzz - "FDA Approves First Biosimilar to a Monoclonal Antibody; Related Litigation is Progressing but Remains Pending"
April 29, 2016
Indianapolis
RELATED PEOPLE
Partner
Food, Drug and Device Practice Chair
F
317-231-7433
×
Subscribe
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you're interested in learning more about.
View Subscription Center
